Genialis
Genialis is a computational precision medicine company unraveling complex biology to find new ways to address disease. ResponderID™, Genialis’ clinical biomarker discovery platform, defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development.
70.8
70.8
NaN
NaN
NaN
NaN
Valuation
$
Valuation
Funding
$
$ 13.00 M
$ 15.36 M
Funding
$ 13.00 M
$ 15.36 M
Statistics
NA
Ventures > Genialis
Genialis
Active
Action
Genialis is a computational precision medicine company unraveling complex biology to find new ways to address disease. ResponderID™, Genialis’ clinical biomarker discovery platform, defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development.
- Funding
0and0